Evaluation and Management of Congenital Bleeding Disorders

被引:4
作者
Bhat, Rahul [1 ]
Cabey, Whitney [1 ]
机构
[1] Georgetown Univ Hosp, Washington Hosp Ctr, Dept Emergency Med, Washington, DC 20010 USA
关键词
Congenital; Bleeding; Hemophilia; von Willebrand; Factor; Coagulopathy; Platelet dysfunction; VON-WILLEBRAND-DISEASE; SEVERE VONWILLEBRAND DISEASE; NORMAL PLATELET TRANSFUSION; FACTOR VIIA NOVOSEVEN(R); HEMOPHILIA-A; FACTOR-IX; DESMOPRESSIN DDAVP; INTRACRANIAL HEMORRHAGE; FACTOR CONCENTRATE; HIGH-PURITY;
D O I
10.1016/j.emc.2014.04.009
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Patients presenting to the emergency department with acute bleeding and a history of clotting or platelet disorder present a unique challenge to the emergency physician. The severity of bleeding presentation is based on mechanism as well as factor levels: patients with factor levels greater than 5% can respond to most minor hemostatic challenges, whereas those with factor levels less than 1% bleed with minor trauma or even spontaneously. Treatment should be initiated in consultation with the patient's hematologist using medications and specific factor replacement, except in rare, life-threatening, resource-poor situations, when cryoprecipitate or activated prothrombin complex may be considerations.
引用
收藏
页码:673 / +
页数:19
相关论文
共 71 条
[1]   A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study [J].
Astermark, Jan ;
Donfield, Sharyne M. ;
DiMichele, Donna M. ;
Gringeri, Alessandro ;
Gilbert, Steven A. ;
Waters, Jennifer ;
Berntorp, Erik .
BLOOD, 2007, 109 (02) :546-551
[2]  
BERGAMASCHINI L, 1995, J LAB CLIN MED, V125, P348
[3]   Modern haemophilia care [J].
Berntorp, Erik ;
Shapiro, Amy D. .
LANCET, 2012, 379 (9824) :1447-1456
[4]   Severe hyponatraemia secondary to desmopressin therapy in von Willebrand's disease [J].
Bertholini, DM ;
Butler, CS .
ANAESTHESIA AND INTENSIVE CARE, 2000, 28 (02) :199-201
[5]   Plasma and albumin-free recombinant factor VIII: pharmacokinetics, efficacy and safety in previously treated pediatric patients [J].
Blanchette, V. S. ;
Shapiro, A. D. ;
Liesner, R. J. ;
Navarro, F. Hernandez ;
Warrier, I. ;
Schroth, P. C. ;
Spotts, G. ;
Ewenstein, B. M. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2008, 6 (08) :1319-1326
[6]   The Diagnosis and Management of Congenital Hemophilia [J].
Carcao, Manuel D. .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2012, 38 (07) :727-734
[7]  
CASTILLO R, 1991, BLOOD, V77, P1901
[8]   Hemostasis in patients with severe von Willebrand disease improves after normal platelet transfusion and normalizes with further correction of the plasma defect [J].
Castillo, R ;
Escolar, G ;
Monteagudo, J ;
AznarSalatti, J ;
Reverter, JC ;
Ordinas, A .
TRANSFUSION, 1997, 37 (08) :785-790
[9]  
Ciavarella N, 1996, HAEMOSTASIS, V26, P150
[10]   Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV [J].
Darby, Sarah C. ;
Kan, Sau Wan ;
Spooner, Rosemary J. ;
Giangrande, Paul L. F. ;
Hill, Frank G. H. ;
Hay, Charles R. M. ;
Lee, Christine A. ;
Ludlam, Christopher A. ;
Williams, Michael .
BLOOD, 2007, 110 (03) :815-825